Aker BioMarine's krill powder appears as useful as krill oil.
Krill oil supplier Aker BioMarine ASA (Oslo, Norway) is eager to promote the findings of a study on Superba krill powder. In what appears to be the first-ever study on krill powder in humans, the Superba product improved omega-3 blood levels while lowering levels of anandamide-a lipid-signaling molecule that tends to be hyperactive in obese humans and animals.
For 24 weeks, 11 obese men consumed 4 g of krill powder daily in capsule form. At 12 and 24 weeks, omega-3 DHA and EPA levels improved and triglycerides dropped more than 20% below baseline measurements. Levels of anandamide decreased by 59% and 84%, respectively. The results from krill powder appear to complement much of the existing research on krill oil in humans and animals.
Krill powder is currently uncommon to the krill ingredients market-although Olympic Seafood AS (FosnavÃ¥g, Norway) is another supplier of krill powder-but it could hold some formulating advantages over the traditional oil. So far, Aker says its free-flowing krill powder contains oil and proteins, and can be incorporated into capsules and tablets. There’s likely more under wraps, as the company is still in the development phase of this product.
Yili to pilot Xampla’s microscopic natural biopolymer capsules for nutrient fortification
July 17th 2024Xampla, a manufacturer natural biopolymers, has announced a partnership with Yili Innovation Centre Europe to test and validate Xampla’s microscopic natural biopolymer capsules used to fortify a range of products with vitamins and nutrients.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.